Dermata Therapeutics, Inc. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DRMAW and buy or sell other stocks, ETFs, and their options commission-free!About DRMAW
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.
CEOGerry Proehl, MBA
CEOGerry Proehl, MBA
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees—
Employees—
DRMAW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume154.67
Average volume154.67
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.044
52 Week high$0.044
52 Week low$0.007
52 Week low$0.007